John Iwanicki comments on the Ariad Pharmaceuticals Inc. v. Eli Lilly & Co. case.

October 8, 2009

Mr. Iwanicki discusses the significance of the Federal Circuit rehearing the Ariad Pharmaceuticals v. Eli Lilly case and who should be watching this case, in an IP Law 360 article titled: Fed. Circ. To Weigh In On Written Description Rule.

Posted: October 8, 2009

Contact Banner Witcoff Share on LinkedIn View this page as a pdf Share on Twitter Email this page Print this page